Insider Trading & Ownership - Cox John

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cox John
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-09-04
Purchase
2024-09-04
5:42 pm
Dyne Therapeutics Inc.DYNCox John
CEO & President
32,000$33.04$1,057,21613,000
(Indirect
Direct)
View
2020-03-24
Sale
2020-03-26
7:31 pm
REPLIGEN CORPRGENCox John
Director
1,858$96.72$179,706923
(Direct)
View
2020-03-18
Sale
2020-03-20
4:25 pm
REPLIGEN CORPRGENCox John
Director
26,736$95.27$2,547,0352,781
(Direct)
View
2020-03-04
Sale
2020-03-05
5:52 pm
REPLIGEN CORPRGENCox John
Director
10,000$93.39$933,90016,781
(Direct)
View
2020-02-24
Sale
2020-02-26
4:27 pm
REPLIGEN CORPRGENCox John
Director
4,455$92.81$413,4552,781
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-12-04
Option Award
2024-12-06
4:05 pm
N/A
2034-12-03
Dyne Therapeutics Inc.DYNCox John
CEO & President
377,400$0414,400
(Direct)
View

Ownership(A)
2024-04-04
9:07 pm
N/A
N/A
Dyne Therapeutics Inc.DYNCox John
CEO & President
0$05,000
(Direct)
View
2024-03-25
Option Award
2024-03-27
4:24 pm
N/A
2034-03-24
Dyne Therapeutics Inc.DYNCox John
See Remarks
679,853$0679,853
(Direct)
View

Ownership
2024-03-27
4:13 pm
N/A
N/A
Dyne Therapeutics Inc.DYNCox John
See Remarks
0$010,000
(Direct)
View
2023-08-11
Disposition
2023-08-11
4:10 pm
N/A
2032-05-25
Sigilon Therapeutics Inc.SGTXCox John
Director
683$4.99840
(Direct)
View
2023-08-11
Disposition
2023-08-11
4:10 pm
N/A
N/A
Sigilon Therapeutics Inc.SGTXCox John
Director
341$00
(Direct)
View
2023-08-11
Disposition
2023-08-11
4:10 pm
N/A
2033-05-18
Sigilon Therapeutics Inc.SGTXCox John
Director
683$6.64390
(Direct)
View
2023-05-19
Option Award
2023-05-22
4:20 pm
N/A
2033-05-18
Sigilon Therapeutics Inc.SGTXCox John
Director
8,888$08,888
(Direct)
View
2022-05-26
Option Award
2022-05-27
5:00 pm
N/A
2032-05-25
Sigilon Therapeutics Inc.SGTXCox John
Director
8,888$08,888
(Direct)
View
2021-06-24
Option Award
2021-06-28
07:15 am
N/A
2031-06-23
Sigilon Therapeutics Inc.SGTXCox John
Director
8,888$9.978,888
(Direct)
View
2020-12-08
Conversion
2020-12-10
6:15 pm
N/A
N/A
Sigilon Therapeutics Inc.SGTXCox John
Director
4,444$04,444
(Indirect)
View

Ownership
2020-12-03
8:42 pm
N/A
N/A
Sigilon Therapeutics Inc.SGTXCox John
Director
0$059,999
(Indirect)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
N/A
REPLIGEN CORPRGENCox John
Director
14,000$12.912,781
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
2023-11-15
REPLIGEN CORPRGENCox John
Director
26,736$02,781
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
N/A
REPLIGEN CORPRGENCox John
Director
2,434$38.762,781
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
N/A
REPLIGEN CORPRGENCox John
Director
3,366$26.122,781
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
N/A
REPLIGEN CORPRGENCox John
Director
3,632$41.192,781
(Direct)
View
2020-03-18
Exercise
2020-03-20
4:25 pm
N/A
N/A
REPLIGEN CORPRGENCox John
Director
3,304$42.072,781
(Direct)
View
2020-03-04
Exercise
2020-03-05
5:52 pm
N/A
N/A
REPLIGEN CORPRGENCox John
Director
10,000$12.9116,781
(Direct)
View
2020-03-04
Exercise
2020-03-05
5:52 pm
N/A
2023-11-15
REPLIGEN CORPRGENCox John
Director
10,000$016,781
(Direct)
View
(A) Indicate amendment filing.